Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Future Growth Projections For The Prescription Orthopedic Drugs Market Size?

In recent times, there has been a robust growth in the prescription orthopedic drugs market. It is anticipated to escalate from $48.41 billion in 2024 to $51.06 billion in 2025, registering a compound annual growth rate (CAGR) of 5.5%. The formidable growth during the historic period is primarily due to the heightened prevalence of musculoskeletal disorders, surge in the elderly population, an augmented awareness of osteoporosis treatments, amplified healthcare accessibility in the underdeveloped regions, as well as the escalation of sports-oriented injuries globally.

The market for prescription orthopedic medications is predicted to experience substantial expansion over the upcoming years, growing to a size of “$63.86 billion by 2029 with an average annual growth rate (CAGR) of 5.8%. The factors driving this growth during the forecast period include an increasing demand for biologics, a rising geriatric population, extended healthcare reach in developing markets, an increased occurrence of chronic musculoskeletal disorders, and enhanced investments towards orthopedic drug R&D. Key forecast trends such as improved targeted biologics, the implementation of regenerative medicine treatments, the personalization of drug formulations, advancements in less-invasive delivery methods, increased drug effectiveness through gene therapy, innovative injectable formulations, and the application of artificial intelligence in drug development and clinical decision making are also significant contributors to this growth.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21263&type=smp

What Market Forces Are Contributing To The Growth Of The Prescription Orthopedic Drugs Market?

Growth in the prescription orthopedic drugs market is anticipated to be amplified by the rising prevalence of musculoskeletal conditions. Such conditions, known as Musculoskeletal disorders (MSDs), include ailments and injuries that detrimentally impact the operation of the human body’s musculoskeletal setup consisting of muscles, tendons, ligaments, nerves, and joints. This leads to discomfort and a decline in mobility. The mounting occurrence of these disorders is chiefly attributable to factors like aging, occupational tasks involving recurring movements and awkward body positions, lifestyle decisions such as insufficient physical activity and poor diet, and genetic factors. Critical in addressing these maladies, prescription orthopedic drugs mitigate pain, curtail inflammation, and accelerate the recovery process, leading to enhanced mobility and overall life quality. For example, the Office for Health Improvement and Disparities, a UK-based public health government department, reported in March 2023 that, in 2022, the proportion of individuals over 16 with enduring musculoskeletal conditions like arthritis or persistent back or joint issues had risen to 17.6% from 17.0% in 2021. Plus, data from the World Health Organization, a Switzerland-based international organization, in July 2022 indicated that around 1.71 billion people globally experience musculoskeletal ailments. Thus, this growing prevalence of musculoskeletal disorders is propelling the expansion of the prescription orthopedic drugs market.

How Does The Prescription Orthopedic Drugs Market Differ By Segment?

The prescription orthopedic drugs market covered in this report is segmented –

1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types

2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin

2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tramadol

3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone

4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine

5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections

What New Opportunities Are Emerging From Trends In The Prescription Orthopedic Drugs Market?

Key corporations in the market for prescription orthopedic drugs are concentrating on extending their drugs’ indications to widen their market penetration, improve patient outcomes, and cater to the underserved medical necessities in various orthopedic conditions. In January 2023, for example, Heron Therapeutics Inc., an American biotech firm, was granted FDA approval for extended use of ZYNRELEF (bupivacaine and meloxicam) in both soft tissue and orthopedic procedure, including surgeries of the foot and ankle. This distinctively engineered extended-release solution offers long lasting pain relief for up to 72 hours, potentially removing the requirement for post-surgery opioids. With additional orthopedic and soft tissue procedures now catered to by the widened indication, its applicability in clinical scenarios has been amplified. This trailblazing combination drug offers both local anesthetic and anti-inflammatory upside, positioning it as a comprehensive solution for management of post-surgery pain, thus bettering patient outcomes.

Who Are The Most Influential Companies In The Prescription Orthopedic Drugs Market?

Major companies operating in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/prescription-orthopedic-drugs-global-market-report

Which Region Is Leading Innovation In The Prescription Orthopedic Drugs Market?

North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21263&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model